Viewing StudyNCT04473040



Ignite Creation Date: 2024-05-06 @ 2:56 PM
Last Modification Date: 2024-10-26 @ 1:40 PM
Study NCT ID: NCT04473040
Status: AVAILABLE
Last Update Posted: 2023-10-25
First Post: 2020-07-10

Brief Title: Managed Access Program to Provide Access to Alpelisib for Patients With Advanced Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
HR HER2- Advanced Breast Cancer
Keywords:
Name View
BYL719 View
hormone receptor positive View
HER2-negative View
breast cancer View
PIK3CA gene View
alpelisib View
Expanded access View
advanced breast cancer View
stage IV View